Synopsis: Enalapril maleate 1 is an orally active angiotensin-converting enzyme inhibitor. It
lowers peripheral vascular resistance without causing an increase in heart rate. Enalapril 10 …

Recently there has been extensive development of orally active angiotensin converting
enzyme (ACE) inhibitors in addition to those already marketed, for example, captopril …

Heart failure (HF) with preserved ejection fraction (HFpEF) is present in about 50% of HF
patients. Atrial remodeling is common in HFpEF and associated with increased mortality. We …

• The purpose of this study was to define the effect of the angiotensin-converting enzyme
inhibitor, enalapril maleate, on blood pressure, renal function, protein excretion, and …

Renal function and antihypertensive drug efficacy were determined in a prospective, double-
blind, multicenter study comparing enalapril plus hydrochlorothiazide with standard triple …

Effects of antihypertensive treatment in one–clip, two kidney hypertension in rats. In order to
investigate the consequences of antihypertensive therapy on hormonal and renal …

This report describes the clinical course, diagnostic evaluation and management of six
children with bilateral renal artery stenosis (RAS) and concurrent narrowing of the …

Enalapril maleate is a new angiotensin converting enzyme inhibitor marketed in the US by
Merck Sharp and Dohme. It has been demonstrated to actively interfere with the renin …

Renin was discovered more than a century ago as a pressor principle in renal extracts.
Subsequent research has revealed the renin-angiotensin system to be fascinatingly …

Two angiotensin converting enzyme inhibitors are currently available for clinical use.
Captopril, a sulfhydryl-containing compound, is a direct acting enzyme inhibitor. Enalapril is …